MedBright AI Announces the Appointment of Christopher Heath as CEO and Termination of Letter of Intent
09 août 2024 08h00 HE
|
MedBright AI Investments Inc.
VANCOUVER, British Columbia, Aug. 09, 2024 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (the "Company" or "MedBright AI") (CSE:MBAI, OTCQB:MBAIF, FSE:Y30) is pleased to announce that...
MedBright AI Announces Strategic Acquisition by Numinus Wellness
20 juin 2024 07h00 HE
|
MedBright AI Investments Inc.
MedBright AI Announces Strategic Acquisition by Numinus Wellness
MedBright AI Announces New Commercial Product Demos for MedMatrix AI Platform
02 mai 2024 07h30 HE
|
MedBright AI Investments Inc.
MedBright AI Announces New Commercial Product Demos for MedMatrix AI Platform
Southern California Clinic Signs Multi-Year Deal for MedMatrix AI Platform
16 avr. 2024 07h30 HE
|
MedBright AI Investments Inc.
Southern California Clinic Signs Multi-Year Deal for
MedMatrix AI Platform
Rejuvenation Medical Group of Canada uses MedMatrix AI Reporter to Streamline Reporting and Improve Operations
19 mars 2024 08h00 HE
|
MedBright AI Investments Inc.
Rejuvenation Medical Group of Canada uses MedMatrix AI Reporter to Streamline Reporting and Improve Operations
Southern California Clinic uses MedMatrix AI Market Expander to Launch Opening of New Clinic Locations
12 mars 2024 07h30 HE
|
MedBright AI Investments Inc.
Southern California Clinic uses MedMatrix AI Market Expander to Launch Opening of New Clinic Locations
MedMatrix Go-to-Market Pricing Announced for AI Product Suite Addressing US$726 Billion Market
05 mars 2024 07h30 HE
|
MedBright AI Investments Inc.
MedMatrix Go-to-Market Pricing Announced for AI Product Suite Addressing US$726 Billion Market
MedMatrix Product Moves from Beta to Full Commercialization, Announces AI Product Suite
27 févr. 2024 08h00 HE
|
MedBright AI Investments Inc.
MedMatrix Product Moves from Beta to Full Commercialization, Announces AI Product Suite
MedBright AI Announces Limmi Disease Insights Platform Being Used in University Hospital Setting to Improve Detection of Kidney Stone Disease Recurrence
22 févr. 2024 08h00 HE
|
MedBright AI Investments Inc.
MedBright AI Announces Limmi Disease Insights Platform Being Used in University Hospital Setting to Improve Detection of Kidney Stone Disease Recurrence
MedBright AI Announces Closing of LIFE Offering for Gross Proceeds of Approximately $1.4 Million
09 févr. 2024 09h27 HE
|
MedBright AI Investments Inc.
MedBright AI Announces Closing of LIFE Offering for Gross Proceeds of Approximately $1.4 Million